Recce Pharma heading closer to full efficacy data for flagship R327
Recce Pharma (ASX:RCE) has announced the latest cohort of patients part of…
Recce Pharmaceuticals Ltd (ASX:RCE)
About Recce Pharmaceuticals Ltd
Key Information
RCE In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 15/05/2024 | Price Sensitive PS Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort | 239.86KB | 1.8K |
| 10/05/2024 | Cleansing Statement | 195.17KB | 291 |
| 10/05/2024 | Application for quotation of securities - RCE | 17.23KB | 305 |
| 09/05/2024 | Price Sensitive PS MCRI Pilot Study- Positive Efficacy Data for Lung Infections | 498KB | 4.5K |
| 07/05/2024 | Price Sensitive PS China Patent Granted for RECCE Anti-Infectives | 241.55KB | 1.9K |
| 26/04/2024 | Price Sensitive PS Safety Committee Approves High Dose of 4,000mg | 263.52KB | 2.9K |
| 22/04/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 575.83KB | 2.1K |
| 16/04/2024 | Cleansing Statement | 193.34KB | 312 |